drugset / Trial / NCT00618241

Pharmacokinetic Study on Raltegravir and Lamotrigine

NCT00618241

RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to determine whether interactions between raltegravir and lamotrigine take place and to study the safety of the combination raltegravir/lamotrigine before used in HIV patients.

Timeline

Start
2008-02
Primary completion
2008-10
Completion
2008-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Lamotrigine Small molecule 100 mg Oral
Subject Raltegravir Other / unclassified 400 mg Oral